Pure Global

Abbott Murex Anti-HCV (Version 4.0) - Taiwan Registration bd186be603a8ac442cc2d23b7a97e3d9

Access comprehensive regulatory information for Abbott Murex Anti-HCV (Version 4.0) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number bd186be603a8ac442cc2d23b7a97e3d9 and manufactured by DIASORIN S.P.A. UK BRANCH. The authorized representative in Taiwan is ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.).

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
bd186be603a8ac442cc2d23b7a97e3d9
Registration Details
Taiwan FDA Registration: bd186be603a8ac442cc2d23b7a97e3d9
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Abbott Murex Anti-HCV (Version 4.0)
TW: ไบžๅŸน"ๅฆ™่Šฎ็ตฒ" Cๅž‹่‚็‚Ž็—…ๆฏ’ๆŠ—้ซ”ๆชข้ฉ—่ฉฆๅŠ‘(็ฌฌๅ››ไปฃ)
Risk Class 3
MD

Registration Details

bd186be603a8ac442cc2d23b7a97e3d9

Ministry of Health Medical Device Import No. 032111

DHA05603211103

Company Information

Product Details

This product uses enzyme immunoassay to test for hepatitis C virus (HCV) antibodies in human serum or plasma.

B Hematology and pathology devices

B4020 Analyze specific reagents

Imported from abroad

Dates and Status

Jan 10, 2019

Jan 10, 2024